LQDA LIQUIDIA CORP
2026Q1 · CUSIP 53635D202 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
242
Δ holders QoQ
+16
Breadth percentile
Top 19%
Whale holders
108
Δ whales
+4
Inst. holding value
$2.3B
New positions
54
Closed positions
38
Price momentum (1Q)
+68.4%
Put / Call
17/19
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 19% | — | — |
| 2025Q3 | Top 14% | +23.4% | +117.5% |
| 2024Q3 | Top 20% | +64.1% | +58.5% |
| 2024Q1 | Top 13% | -23.0% | -22.6% |
| 2022Q3 | Top 15% | +64.2% | +74.0% |
| 2022Q2 | Top 8% | -34.0% | -5.6% |
| 2022Q1 | Top 11% | +19.8% | -19.0% |
| 2020Q2 | Top 10% | -31.9% | -38.5% |
Options Sentiment
Put holders
17
QoQ: -1
Call holders
19
QoQ: +6
See methodology →
Fundamentals
PE (TTM)
470.2
EPS (TTM)
$0.17
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+1936.7%
Net margin
7.7%
ROE
20.5%
Debt ratio
73.0%
FCF (TTM)
$41M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.